ReSurfX is an 'outcomes intelligence' company enabling better decisions. innovation, outcomes and ROI for enterprises from their data-intensive activities, with primary focus on healthcare (including Pharma, biotech and patient care). The enterprise software product ReSurfX::vysen offered by ReSurfX as SaaS leverages a novel data-source agnostic machine learning approach 'Adaptive Hypersurface Technology' (AHT) invented by Suresh Gopalan providing Artificial Intelligence (AI)-driven suite of functionalities and technology redesign solutions, including the proprietary 'Advance Outcomes Alert System'. The solutions leveraging AHT have been shown to be the best-in-class, including the SyRTOP AI predictor configuration of ReSurfX::vysen.
In two recently released analysis we demonstrated a never before achieved reduction of false positives by use of our product ReSurfX::vysen on a data that has been extensively studied to develop numerous analytic technologies. That data is from large-scale gene expression technology analysis – Read on.. don’t let that field of application sway your interest. This never before possible level of accuracy was made possible by a breakthrough data-source agnostic 'Adaptive Hypersurface Technology' (AHT) that ReSurfX is leveraging in data-analytics and continuing to develop. Here, we discuss the state-of-the-art in data-analytics, current thoughts and problems (from popular media and authoritative source). What does it mean for your innovation and ROI?